Ocean Beach Pier, San Diego, with surf rolling beneath the dock

La Jolla Counted the Quiet Ones

The thing about a practice that happens in private is that nobody knows how big it is until someone bothers to count. Last month, researchers down the road in La Jolla did the counting. The number is larger than the skeptics assumed and quieter than the headlines usually make it. If you KNOW, you already had a hunch.

What the survey actually found

On May 4, a team out of UC San Diego published the first nationally representative estimate of microdosing in the United States in the American Journal of Preventive Medicine. Working from a probability-based panel of 1,525 adults, they extrapolated to the whole country. Cannabis led by a wide margin, with about 9.4 percent of adults — roughly 24.1 million people — reporting they had microdosed it at some point. Psilocybin came next at 5.3 percent (around 13.7 million), then LSD at 4.8 percent (12.4 million), and MDMA at 2.2 percent (5.7 million).

Those aren't fringe figures. They describe a habit that millions of ordinary people have folded into ordinary life without telling their doctor, their boss, or the survey-takers who never asked before now. The researchers were careful about what the data can and can't say: this is a snapshot of who and why, not proof that any of it works. The science on whether tiny doses do what people hope is still thin, still mixed, still waiting on the controlled trials.

The reason behind the doses

The more interesting column wasn't how many. It was why. Cannabis microdosers leaned medical — about 41 percent said they were managing something, usually pain. The classic psychedelics ran the other direction. Two-thirds of psilocybin microdosers, and most of the LSD and MDMA crowd, described their reason in a phrase that should tell you everything about how this practice works in real life: they wanted to get less high. Less, not more. The whole point was to feel a floor of something — steadier mood, sharper focus, a softer edge on a hard week — without leaving the ground.

That's harm reduction whether anyone calls it that or not. The instinct to take the smallest amount that does anything, to stay functional, to keep the dose under the experience rather than chasing it, is the same instinct that built every sane drug-using subculture worth respecting. It's not the rave talking. It's people quietly trying to feel okay on a Tuesday.

None of this lands as a surprise to anyone who's been paying attention to the corners where surfers, skaters, and the generally unimpressed have always done their own quiet experiments. The survey just put a number on what those corners already knew. Science is slow to count what people have been doing all along, and the gap between the lived thing and the measured thing is where most of the interesting stuff lives. Know your piers. The people standing on them have usually figured out the tide before the forecast does.

The data is a map, not a permission slip. Millions of people microdosing doesn't make it proven, safe, or right for you — it makes it real, and worth understanding clearly instead of through a haze of hype or panic. That's the whole game. Nibble on the enigma. Don't swallow it whole.

Sources:

This post is editorial reporting. Nothing here is medical advice. Psychedelic compounds are controlled substances in most jurisdictions. If you're struggling, talk to a licensed professional.

Back to blog